Journals / Retina-Vitreus / 2006 / Cilt: 14 - Sayı: 4

Pars plana vitrectomy, internal limiting membrane peeling and radial optic neurotomy in central retinal vein occlusions

Santral retinal ven tıkanıklıklarında pars plana vitrektomi, internal limitan membran soyulması ve radyal optik nörotomi

Pages
257–262
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

For CRVO management, multi-centered randomised and controlled studies are needed, in order to define RON indication and appropriate treatment timing.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the efficiency of vitrectomy, internal limiting membrane (ILM) peeling and radial optic neurotomy (RON) performed for internal optic decompression, in cases with central retinal vein occlusion (CRVO).
📊
Key Findings & Data:Materials and Methods: Pars plana vitrectomy (PPV), ILM peeling and RON were performed in 7 eyes of 7 cases with CRVO, whose visual acuities were 0.1 or less in Snellen lines and who had preoperative period of at least 1 month.
💡
Conclusion & Impact:For CRVO management, multi-centered randomised and controlled studies are needed, in order to define RON indication and appropriate treatment timing.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the efficiency of vitrectomy, internal limiting membrane (ILM) peeling and radial optic neurotomy (RON) performed for internal optic decompression, in cases with central retinal vein occlusion (CRVO). Materials and Methods: Pars plana vitrectomy (PPV), ILM peeling and RON were performed in 7 eyes of 7 cases with CRVO, whose visual acuities were 0.1 or less in Snellen lines and who had preoperative period of at least 1 month. Photocoagulation was not done in any of the patients. In order to evaluate the outcomes of RON; full ophthalmological examination, colored fundus photography and fluorescein angiographies were done preoperatively and postoperatively. Results: The mean period between CRVO development and surgery was 19.29±23.21 weeks (range:4-60); the mean postoperative follow-up period was 21.57±6.92 months (range:12-30). The mean visual acuity was 0.03±0.35 (0.01-0.1) preoperatively, 0.05±0.38 (0.01-0.1) postoperatively at the last followup (p=0.421). Fundus fluorescein angiography (FFA) revealed significant decrease in vascular dilatation and tortuosity in all 7 cases postoperatively. However, there were no significant changes in ischemic areas and macular edema. Chorioretinal anastomosis was detected in 3 of the 7 cases (43%). Postoperatively, 1 case had nasal artery branch occlusion and 1 case had epiretinal membrane formation and gliosis in RON site. None of the cases had postoperative rubeosis iridis or neovascular glaucoma. Conclusion: In CRVO cases, PPV and RON results in significant improvement in angiographic vascular dilatation and tortuosity in early postoperative period, but it is not associated with any significant change in ischemia. For CRVO management, multi-centered randomised and controlled studies are needed, in order to define RON indication and appropriate treatment timing.

Özet

Amaç: Santral retinal ven tıkanıklığı (SRVT) gelişen olgularda internal optik dekompresyon amacıyla yapılan vitrektomi, iç limitan membran (İLM) soyulması ve radyal optik nörotominin (RON) etkinliğini değerlendirmek. Gereç ve Yöntem: Santral retinal ven tıkanıklığı gelişen, görme seviyesi 0.1 Snellen sırası ve altında olan ve en az 1 ay bekleme süresi olan 7 hastanın 7 gözüne pars plana vitrektomi (PPV), iç limitan membran soyulması ve radyal optik nörotomi (RON) uygulandı. Hiçbir hastaya fotokoagulasyon yapılmadı. RON sonuçlarını değerlendirmek için cerrahi öncesi ve sonrası oftalmolojik muayene, renkli fundus fotoğrafları ve flöresein anjiografileri çekildi. Bulgular: SRVT gelişimi ile cerrahi arası süre ortalama 19.29±23.21 (4-60) hafta; postoperatif takip süresi ortalama 21.57±6.92 (12-30) aydı. Tedavi öncesi ortalama görme keskinliği 0.03±0.35 (0.01-0.1) iken, postoperatif son kontrolde görme keskinliği 0.05±0.38 (0.01-0.1) idi (p=0.421). Fundus flöresein anjiografisinde (FFA) radyal optik nörotomi uygulanan 7 olguların tümünde postoperatif damar dilatasyonu ve kıvrımlarında belirgin azalma saptandı.Fakat iskemik alanlarda ve makula ödeminde belirgin değişiklik olmadı. Üç olguda (%43) korioretinal anastomoz saptandı. Komplikasyon olarak bir olguda postoperatif nazal arter dal oklüzyonu gelişti. Bir olguda ise epiretinal membran ve RON yerinde gliozis gelişti. Hiçbir olguda cerrahi sonrası rubeozis iridis ve neovasküler glokom saptanmadı. Sonuç: SRVT olgularında PPV ve RON, anjiografik olarak erken dönemde damar dilatasyonu ve kıvrımlarında belirgin düzelme sağlamakta, fakat iskemide belirgin değişiklik yapmamaktadır. SRVT’de RON endikasyonu ve uygun tedavi zamanlamasını belirlemek için çok merkezli, randomize ve kontrollü çalışmalar gerekmektedir.

🔖

Cite This Article

ÇAKIR, M., OVALI, T., UTİNE, C. A. (2006). Pars plana vitrectomy, internal limiting membrane peeling and radial optic neurotomy in central retinal vein occlusions. Retina-Vitreus, Cilt: 14 - Sayı: 4, 257–262. https://ajindex.com/articles/305339

References (17)

  1. The Central Vein Oclusion Study Group.: Baseline and early natural history report: The central Vein Occlusion study. Arch Ophthalmol. 1993;111:1087-1095
  2. The Central Vein Occlusion Study Group.: Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol. 1997;115:486-491
  3. Hayreh SS.: Classification of central retinal occlusion. Ophthalmology. 1983;90:458-474
  4. Gren WR,Chan CC, Hutchins GM, et al.: Central retinal vein occlusion: A prospective histopathologic study of 29 eyes of 28 cases. Retina. 1981;1:27-55
  5. Zegarra H, Gutman FA, Conforto J.: Natural course of central retinal vein occlusion. Ophthalmology. 1979;86:931-939
  6. Hayreh SS, Zimmerman MB, podhajsky P.: Incidence of varius types of retinal vein occluion and their recurrence and emographi characteristics. Am J Ophthalmol. 1994;11 7:429-441
  7. The Eye Disease Case-Control Study Group: Risk factors for central retinal vein occlusions. Rch ophthalmol. 1 996; 114:545-554
  8. Hayreh SS.: Reply to radial optic neurotomy needs evaluation in a controlled prospective trial. Ophthalmologica. 2004;21 8:145-146
  9. Williamson T.H.: Central retinal vein occlusion: what's the story? British J Ophthalmol. 1997;81:698-704
  10. The Central Vein Occlusion Study Group: Report Evaluation of grid pattern photocoagulation for maular edema in central vein occlusion. Ophthalmology. 1995;102:1425-1433
  11. McAlister IL, Douglas JP, Constable IJ, et al.: Laser induced chorioretinal anastomosis for non-ischemic centrl retinal vein occlusion: evluation of the complications an their risk factors. Am J Ophthalmol. 1998;126:219-229
  12. Opremcak EM, Bruce RA, Lomeo MD et al.: Radial optic neurotomy for central retinal vein occlusion; a retrospective pilot study of 1 1 consecutive cases. Retina. 2001;21:408-415
  13. Horio N, Horiguchi M.: Central retinal vein occlusion with further reduction of retinal blood flow one year after radial optic neurotomy. Am J Ophthalmol. 2005;139:926-927
  14. Peymon GA, Kishore K, Conway MP.: Surgical chorioretinal venous anastomosis for ischemic central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30:605-614
  15. Arciniegas A: Treatment of the occlusion of the central retinal vein by section of the posterior ring. Ann Ophthalmol. 1 984; 16:1 081 -1086
  16. Dev S, Buckley EG.: Optice nevre sheath decompression for progressive central retinal vein occlusion.Ophthalmic Surg lasers. 1999;30:181-184
  17. Hikichi T, Konno S, Trempe CL: Role of the